Hospital Universitario de Navarra
Pamplona 31008
9 studies enrolling now · 17 studies all time
What they study most
Acinar Cell Carcinoma, Advanced Cancer, Advanced/Metastatic Solid Tumors, Aortic Diseases, Atrial Fibrillation, CRC (Colorectal Cancer), Carotid Artery Diseases, Colorectal Cancer, Coronary Artery Disease, Cutaneous Lupus Erythematosus (CLE), Endometrial Cancer, Esophageal Cancer
Studies at this site
- A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
- A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01) — Recruiting now
- A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — Recruiting now
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors — Recruiting now
- Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
- Intervascular Post-Market Clinical Follow-Up (PMCF) Registry — Recruiting now
- The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C) — Recruiting now
- Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress — Recruiting now
- Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer — Withdrawn before enrolling
- RegoNivo vs Standard of Care Chemotherapy in AGOC — Completed
- A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy — Running, not enrolling
- Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE) — Stopped early
- A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) — Running, not enrolling
- Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) — Running, not enrolling
- Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) — Running, not enrolling
- Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors — Status unconfirmed